Sacroiliac Joint Fusion Market Size, Share & Trends Analysis Report By Indication (Degenerative Sacroiliitis, Sacral Disruption), By Treatment Type (Surgery, Injections), By End-user, By Region, And Segment Forecasts, 2024 - 2030
- Report ID: GVR-4-68039-805-9
- Number of Pages: 162
- Format: Electronic (PDF)
- Historical Range: 2018 - 2022
- Industry: Healthcare
Market Segmentation
- Sacroiliac Joint Fusion Indication Outlook (Revenue, USD Million, 2018 - 2030)
- Degenerative sacroiliitis
- Sacral disruption
- Trauma
- Sacroiliac Joint Fusion Treatment Type Outlook (Revenue, USD Million, 2018 - 2030)
- Surgery
- By Surgery Type
- MIS
- MIS
- By Approach
- Dorsal
- Anterior
- By Product
- Implants
- Accessories
- By Surgery Type
- Injections
- Diagnosis
- Treatment
- RF Ablation
- Surgery
- Sacroiliac Joint Fusion End User Outlook (Revenue, USD Million, 2018 - 2030)
- Hospitals
- Ambulatory surgical centers
- Others (Specialty Centers, Research & Academic Institutes)
- Sacroiliac Joint Fusion Regional Outlook (Revenue, USD Million, 2018 - 2030)
- North America
- North America Indication Outlook (Revenue, USD Million, 2018 - 2030)
- Degenerative sacroiliitis
- Sacral disruption
- Trauma
- North America Treatment Type Outlook (Revenue, USD Million, 2018 - 2030)
- Surgery
- By Surgery Type
- MIS
- MIS
- By Approach
- Dorsal
- Anterior
- By Product
- Implants
- Accessories
- By Surgery Type
- Injections
- Diagnosis
- Treatment
- RF Ablation
- Surgery
- North America End User Outlook (Revenue, USD Million, 2018 - 2030)
- Hospitals
- Ambulatory surgical centers
- Others (Specialty Centers, Research & Academic Institutes)
- U.S.
- U.S. Indication Outlook (Revenue, USD Million, 2018 - 2030)
- Degenerative sacroiliitis
- Sacral disruption
- Trauma
- U.S. Treatment Type Outlook (Revenue, USD Million, 2018 - 2030)
- Surgery
- By Surgery Type
- MIS
- MIS
- By Approach
- Dorsal
- Anterior
- By Product
- Implants
- Accessories
- By Surgery Type
- Injections
- Diagnosis
- Treatment
- RF Ablation
- Surgery
- U.S. End User Outlook (Revenue, USD Million, 2018 - 2030)
- Hospitals
- Ambulatory surgical centers
- Others (Specialty Centers, Research & Academic Institutes)
- U.S. Indication Outlook (Revenue, USD Million, 2018 - 2030)
- Canada
- Canada Indication Outlook (Revenue, USD Million, 2018 - 2030)
- Degenerative sacroiliitis
- Sacral disruption
- Trauma
- Canada Treatment Type Outlook (Revenue, USD Million, 2018 - 2030)
- Surgery
- By Surgery Type
- MIS
- MIS
- By Approach
- Dorsal
- Anterior
- By Product
- Implants
- Accessories
- By Surgery Type
- Injections
- Diagnosis
- Treatment
- RF Ablation
- Surgery
- Canada End User Outlook (Revenue, USD Million, 2018 - 2030)
- Hospitals
- Ambulatory surgical centers
- Others (Specialty Centers, Research & Academic Institutes)
- Canada Indication Outlook (Revenue, USD Million, 2018 - 2030)
- North America Indication Outlook (Revenue, USD Million, 2018 - 2030)
- Europe
- Europe Indication Outlook (Revenue, USD Million, 2018 - 2030)
- Degenerative sacroiliitis
- Sacral disruption
- Trauma
- Europe Treatment Type Outlook (Revenue, USD Million, 2018 - 2030)
- Surgery
- By Surgery Type
- MIS
- MIS
- By Approach
- Dorsal
- Anterior
- By Product
- Implants
- Accessories
- By Surgery Type
- Injections
- Diagnosis
- Treatment
- RF Ablation
- Surgery
- Europe End User Outlook (Revenue, USD Million, 2018 - 2030)
- Hospitals
- Ambulatory surgical centers
- Others (Specialty Centers, Research & Academic Institutes)
- U.K.
- U.K. Indication Outlook (Revenue, USD Million, 2018 - 2030)
- Degenerative sacroiliitis
- Sacral disruption
- Trauma
- U.K. Treatment Type Outlook (Revenue, USD Million, 2018 - 2030)
- Surgery
- By Surgery Type
- MIS
- MIS
- By Approach
- Dorsal
- Anterior
- By Product
- Implants
- Accessories
- By Surgery Type
- Injections
- Diagnosis
- Treatment
- RF Ablation
- Surgery
- U.K. End User Outlook (Revenue, USD Million, 2018 - 2030)
- Hospitals
- Ambulatory surgical centers
- Others (Specialty Centers, Research & Academic Institutes)
- U.K. Indication Outlook (Revenue, USD Million, 2018 - 2030)
- Germany
- Germany Indication Outlook (Revenue, USD Million, 2018 - 2030)
- Degenerative sacroiliitis
- Sacral disruption
- Trauma
- Germany Treatment Type Outlook (Revenue, USD Million, 2018 - 2030)
- Surgery
- By Surgery Type
- MIS
- MIS
- By Approach
- Dorsal
- Anterior
- By Product
- Implants
- Accessories
- By Surgery Type
- Injections
- Diagnosis
- Treatment
- RF Ablation
- Surgery
- Germany End User Outlook (Revenue, USD Million, 2018 - 2030)
- Hospitals
- Ambulatory surgical centers
- Others (Specialty Centers, Research & Academic Institutes)
- Germany Indication Outlook (Revenue, USD Million, 2018 - 2030)
- France
- France Indication Outlook (Revenue, USD Million, 2018 - 2030)
- Degenerative sacroiliitis
- Sacral disruption
- Trauma
- France Treatment Type Outlook (Revenue, USD Million, 2018 - 2030)
- Surgery
- By Surgery Type
- MIS
- MIS
- By Approach
- Dorsal
- Anterior
- By Product
- Implants
- Accessories
- By Surgery Type
- Injections
- Diagnosis
- Treatment
- RF Ablation
- Surgery
- France End User Outlook (Revenue, USD Million, 2018 - 2030)
- Hospitals
- Ambulatory surgical centers
- Others (Specialty Centers, Research & Academic Institutes)
- France Indication Outlook (Revenue, USD Million, 2018 - 2030)
- Italy
- Italy Indication Outlook (Revenue, USD Million, 2018 - 2030)
- Degenerative sacroiliitis
- Sacral disruption
- Trauma
- Italy Treatment Type Outlook (Revenue, USD Million, 2018 - 2030)
- Surgery
- By Surgery Type
- MIS
- MIS
- By Approach
- Dorsal
- Anterior
- By Product
- Implants
- Accessories
- By Surgery Type
- Injections
- Diagnosis
- Treatment
- RF Ablation
- Surgery
- Italy End User Outlook (Revenue, USD Million, 2018 - 2030)
- Hospitals
- Ambulatory surgical centers
- Others (Specialty Centers, Research & Academic Institutes)
- Italy Indication Outlook (Revenue, USD Million, 2018 - 2030)
- Spain
- Spain Indication Outlook (Revenue, USD Million, 2018 - 2030)
- Degenerative sacroiliitis
- Sacral disruption
- Trauma
- Spain Treatment Type Outlook (Revenue, USD Million, 2018 - 2030)
- Surgery
- By Surgery Type
- MIS
- MIS
- By Approach
- Dorsal
- Anterior
- By Product
- Implants
- Accessories
- By Surgery Type
- Injections
- Diagnosis
- Treatment
- RF Ablation
- Surgery
- Spain End User Outlook (Revenue, USD Million, 2018 - 2030)
- Hospitals
- Ambulatory surgical centers
- Others (Specialty Centers, Research & Academic Institutes)
- Spain Indication Outlook (Revenue, USD Million, 2018 - 2030)
- Denmark
- Denmark Indication Outlook (Revenue, USD Million, 2018 - 2030)
- Degenerative sacroiliitis
- Sacral disruption
- Trauma
- Denmark Treatment Type Outlook (Revenue, USD Million, 2018 - 2030)
- Surgery
- By Surgery Type
- MIS
- MIS
- By Approach
- Dorsal
- Anterior
- By Product
- Implants
- Accessories
- By Surgery Type
- Injections
- Diagnosis
- Treatment
- RF Ablation
- Surgery
- Denmark End User Outlook (Revenue, USD Million, 2018 - 2030)
- Hospitals
- Ambulatory surgical centers
- Others (Specialty Centers, Research & Academic Institutes)
- Denmark Indication Outlook (Revenue, USD Million, 2018 - 2030)
- Sweden
- Sweden Indication Outlook (Revenue, USD Million, 2018 - 2030)
- Degenerative sacroiliitis
- Sacral disruption
- Trauma
- Sweden Treatment Type Outlook (Revenue, USD Million, 2018 - 2030)
- Surgery
- By Surgery Type
- MIS
- MIS
- By Approach
- Dorsal
- Anterior
- By Product
- Implants
- Accessories
- By Surgery Type
- Injections
- Diagnosis
- Treatment
- RF Ablation
- Surgery
- Sweden End User Outlook (Revenue, USD Million, 2018 - 2030)
- Hospitals
- Ambulatory surgical centers
- Others (Specialty Centers, Research & Academic Institutes)
- Sweden Indication Outlook (Revenue, USD Million, 2018 - 2030)
- Norway
- Norway Indication Outlook (Revenue, USD Million, 2018 - 2030)
- Degenerative sacroiliitis
- Sacral disruption
- Trauma
- Norway Treatment Type Outlook (Revenue, USD Million, 2018 - 2030)
- Surgery
- By Surgery Type
- MIS
- MIS
- By Approach
- Dorsal
- Anterior
- By Product
- Implants
- Accessories
- By Surgery Type
- Injections
- Diagnosis
- Treatment
- RF Ablation
- Surgery
- Norway End User Outlook (Revenue, USD Million, 2018 - 2030)
- Hospitals
- Ambulatory surgical centers
- Others (Specialty Centers, Research & Academic Institutes)
- Norway Indication Outlook (Revenue, USD Million, 2018 - 2030)
- Europe Indication Outlook (Revenue, USD Million, 2018 - 2030)
- Asia Pacific
- Asia Pacific Indication Outlook (Revenue, USD Million, 2018 - 2030)
- Degenerative sacroiliitis
- Sacral disruption
- Trauma
- Asia Pacific Treatment Type Outlook (Revenue, USD Million, 2018 - 2030)
- Surgery
- By Surgery Type
- MIS
- MIS
- By Approach
- Dorsal
- Anterior
- By Product
- Implants
- Accessories
- By Surgery Type
- Injections
- Diagnosis
- Treatment
- RF Ablation
- Surgery
- Asia Pacific End User Outlook (Revenue, USD Million, 2018 - 2030)
- Hospitals
- Ambulatory surgical centers
- Others (Specialty Centers, Research & Academic Institutes)
- China
- China Indication Outlook (Revenue, USD Million, 2018 - 2030)
- Degenerative sacroiliitis
- Sacral disruption
- Trauma
- China Treatment Type Outlook (Revenue, USD Million, 2018 - 2030)
- Surgery
- By Surgery Type
- MIS
- MIS
- By Approach
- Dorsal
- Anterior
- By Product
- Implants
- Accessories
- By Surgery Type
- Injections
- Diagnosis
- Treatment
- RF Ablation
- Surgery
- China End User Outlook (Revenue, USD Million, 2018 - 2030)
- Hospitals
- Ambulatory surgical centers
- Others (Specialty Centers, Research & Academic Institutes)
- China Indication Outlook (Revenue, USD Million, 2018 - 2030)
- Japan
- Japan Indication Outlook (Revenue, USD Million, 2018 - 2030)
- Degenerative sacroiliitis
- Sacral disruption
- Trauma
- Japan Treatment Type Outlook (Revenue, USD Million, 2018 - 2030)
- Surgery
- By Surgery Type
- MIS
- MIS
- By Approach
- Dorsal
- Anterior
- By Product
- Implants
- Accessories
- By Surgery Type
- Injections
- Diagnosis
- Treatment
- RF Ablation
- Surgery
- Japan End User Outlook (Revenue, USD Million, 2018 - 2030)
- Hospitals
- Ambulatory surgical centers
- Others (Specialty Centers, Research & Academic Institutes)
- Japan Indication Outlook (Revenue, USD Million, 2018 - 2030)
- India
- India Indication Outlook (Revenue, USD Million, 2018 - 2030)
- Degenerative sacroiliitis
- Sacral disruption
- Trauma
- India Treatment Type Outlook (Revenue, USD Million, 2018 - 2030)
- Surgery
- By Surgery Type
- MIS
- MIS
- By Approach
- Dorsal
- Anterior
- By Product
- Implants
- Accessories
- By Surgery Type
- Injections
- Diagnosis
- Treatment
- RF Ablation
- Surgery
- India End User Outlook (Revenue, USD Million, 2018 - 2030)
- Hospitals
- Ambulatory surgical centers
- Others (Specialty Centers, Research & Academic Institutes)
- India Indication Outlook (Revenue, USD Million, 2018 - 2030)
- Australia
- Australia Indication Outlook (Revenue, USD Million, 2018 - 2030)
- Degenerative sacroiliitis
- Sacral disruption
- Trauma
- Australia Treatment Type Outlook (Revenue, USD Million, 2018 - 2030)
- Surgery
- By Surgery Type
- MIS
- MIS
- By Approach
- Dorsal
- Anterior
- By Product
- Implants
- Accessories
- By Surgery Type
- Injections
- Diagnosis
- Treatment
- RF Ablation
- Surgery
- Australia End User Outlook (Revenue, USD Million, 2018 - 2030)
- Hospitals
- Ambulatory surgical centers
- Others (Specialty Centers, Research & Academic Institutes)
- Australia Indication Outlook (Revenue, USD Million, 2018 - 2030)
- Thailand
- Thailand Indication Outlook (Revenue, USD Million, 2018 - 2030)
- Degenerative sacroiliitis
- Sacral disruption
- Trauma
- Thailand Treatment Type Outlook (Revenue, USD Million, 2018 - 2030)
- Surgery
- By Surgery Type
- MIS
- MIS
- By Approach
- Dorsal
- Anterior
- By Product
- Implants
- Accessories
- By Surgery Type
- Injections
- Diagnosis
- Treatment
- RF Ablation
- Surgery
- Thailand End User Outlook (Revenue, USD Million, 2018 - 2030)
- Hospitals
- Ambulatory surgical centers
- Others (Specialty Centers, Research & Academic Institutes)
- Thailand Indication Outlook (Revenue, USD Million, 2018 - 2030)
- South Korea
- South Korea Indication Outlook (Revenue, USD Million, 2018 - 2030)
- Degenerative sacroiliitis
- Sacral disruption
- Trauma
- South Korea Treatment Type Outlook (Revenue, USD Million, 2018 - 2030)
- Surgery
- By Surgery Type
- MIS
- MIS
- By Approach
- Dorsal
- Anterior
- By Product
- Implants
- Accessories
- By Surgery Type
- Injections
- Diagnosis
- Treatment
- RF Ablation
- Surgery
- South Korea End User Outlook (Revenue, USD Million, 2018 - 2030)
- Hospitals
- Ambulatory surgical centers
- Others (Specialty Centers, Research & Academic Institutes)
- South Korea Indication Outlook (Revenue, USD Million, 2018 - 2030)
- Asia Pacific Indication Outlook (Revenue, USD Million, 2018 - 2030)
- Latin America
- Latin America Indication Outlook (Revenue, USD Million, 2018 - 2030)
- Degenerative sacroiliitis
- Sacral disruption
- Trauma
- Latin America Treatment Type Outlook (Revenue, USD Million, 2018 - 2030)
- Surgery
- By Surgery Type
- MIS
- MIS
- By Approach
- Dorsal
- Anterior
- By Product
- Implants
- Accessories
- By Surgery Type
- Injections
- Diagnosis
- Treatment
- RF Ablation
- Surgery
- Latin America End User Outlook (Revenue, USD Million, 2018 - 2030)
- Hospitals
- Ambulatory surgical centers
- Others (Specialty Centers, Research & Academic Institutes)
- Brazil
- Brazil Indication Outlook (Revenue, USD Million, 2018 - 2030)
- Degenerative sacroiliitis
- Sacral disruption
- Trauma
- Brazil Treatment Type Outlook (Revenue, USD Million, 2018 - 2030)
- Surgery
- By Surgery Type
- MIS
- MIS
- By Approach
- Dorsal
- Anterior
- By Product
- Implants
- Accessories
- By Surgery Type
- Injections
- Diagnosis
- Treatment
- RF Ablation
- Surgery
- Brazil End User Outlook (Revenue, USD Million, 2018 - 2030)
- Hospitals
- Ambulatory surgical centers
- Others (Specialty Centers, Research & Academic Institutes)
- Brazil Indication Outlook (Revenue, USD Million, 2018 - 2030)
- Mexico
- Mexico Indication Outlook (Revenue, USD Million, 2018 - 2030)
- Degenerative sacroiliitis
- Sacral disruption
- Trauma
- Mexico Treatment Type Outlook (Revenue, USD Million, 2018 - 2030)
- Surgery
- By Surgery Type
- MIS
- MIS
- By Approach
- Dorsal
- Anterior
- By Product
- Implants
- Accessories
- By Surgery Type
- Injections
- Diagnosis
- Treatment
- RF Ablation
- Surgery
- Mexico End User Outlook (Revenue, USD Million, 2018 - 2030)
- Hospitals
- Ambulatory surgical centers
- Others (Specialty Centers, Research & Academic Institutes)
- Mexico Indication Outlook (Revenue, USD Million, 2018 - 2030)
- Argentina
- Argentina Indication Outlook (Revenue, USD Million, 2018 - 2030)
- Degenerative sacroiliitis
- Sacral disruption
- Trauma
- Argentina Treatment Type Outlook (Revenue, USD Million, 2018 - 2030)
- Surgery
- By Surgery Type
- MIS
- MIS
- By Approach
- Dorsal
- Anterior
- By Product
- Implants
- Accessories
- By Surgery Type
- Injections
- Diagnosis
- Treatment
- RF Ablation
- Surgery
- Argentina End User Outlook (Revenue, USD Million, 2018 - 2030)
- Hospitals
- Ambulatory surgical centers
- Others (Specialty Centers, Research & Academic Institutes)
- Argentina Indication Outlook (Revenue, USD Million, 2018 - 2030)
- Latin America Indication Outlook (Revenue, USD Million, 2018 - 2030)
- Middle East & Africa
- Middle East & Africa Indication Outlook (Revenue, USD Million, 2018 - 2030)
- Degenerative sacroiliitis
- Sacral disruption
- Trauma
- Middle East & Africa Treatment Type Outlook (Revenue, USD Million, 2018 - 2030)
- Surgery
- By Surgery Type
- MIS
- MIS
- By Approach
- Dorsal
- Anterior
- By Product
- Implants
- Accessories
- By Surgery Type
- Injections
- Diagnosis
- Treatment
- RF Ablation
- Surgery
- Middle East & Africa End User Outlook (Revenue, USD Million, 2018 - 2030)
- Hospitals
- Ambulatory surgical centers
- Others (Specialty Centers, Research & Academic Institutes)
- South Africa
- South Africa Indication Outlook (Revenue, USD Million, 2018 - 2030)
- Degenerative sacroiliitis
- Sacral disruption
- Trauma
- South Africa Treatment Type Outlook (Revenue, USD Million, 2018 - 2030)
- Surgery
- By Surgery Type
- MIS
- MIS
- By Approach
- Dorsal
- Anterior
- By Product
- Implants
- Accessories
- By Surgery Type
- Injections
- Diagnosis
- Treatment
- RF Ablation
- Surgery
- South Africa End User Outlook (Revenue, USD Million, 2018 - 2030)
- Hospitals
- Ambulatory surgical centers
- Others (Specialty Centers, Research & Academic Institutes)
- South Africa Indication Outlook (Revenue, USD Million, 2018 - 2030)
- Saudi Arabia
- Saudi Arabia Indication Outlook (Revenue, USD Million, 2018 - 2030)
- Degenerative sacroiliitis
- Sacral disruption
- Trauma
- Saudi Arabia Treatment Type Outlook (Revenue, USD Million, 2018 - 2030)
- Surgery
- By Surgery Type
- MIS
- MIS
- By Approach
- Dorsal
- Anterior
- By Product
- Implants
- Accessories
- By Surgery Type
- Injections
- Diagnosis
- Treatment
- RF Ablation
- Surgery
- Saudi Arabia End User Outlook (Revenue, USD Million, 2018 - 2030)
- Hospitals
- Ambulatory surgical centers
- Others (Specialty Centers, Research & Academic Institutes)
- Saudi Arabia Indication Outlook (Revenue, USD Million, 2018 - 2030)
- UAE
- UAE Indication Outlook (Revenue, USD Million, 2018 - 2030)
- Degenerative sacroiliitis
- Sacral disruption
- Trauma
- UAE Treatment Type Outlook (Revenue, USD Million, 2018 - 2030)
- Surgery
- By Surgery Type
- MIS
- MIS
- By Approach
- Dorsal
- Anterior
- By Product
- Implants
- Accessories
- By Surgery Type
- Injections
- Diagnosis
- Treatment
- RF Ablation
- Surgery
- UAE End User Outlook (Revenue, USD Million, 2018 - 2030)
- Hospitals
- Ambulatory surgical centers
- Others (Specialty Centers, Research & Academic Institutes)
- UAE Indication Outlook (Revenue, USD Million, 2018 - 2030)
- Kuwait
- Kuwait Indication Outlook (Revenue, USD Million, 2018 - 2030)
- Degenerative sacroiliitis
- Sacral disruption
- Trauma
- Kuwait Treatment Type Outlook (Revenue, USD Million, 2018 - 2030)
- Surgery
- By Surgery Type
- MIS
- MIS
- By Approach
- Dorsal
- Anterior
- By Product
- Implants
- Accessories
- By Surgery Type
- Injections
- Diagnosis
- Treatment
- RF Ablation
- Surgery
- Kuwait End User Outlook (Revenue, USD Million, 2018 - 2030)
- Hospitals
- Ambulatory surgical centers
- Others (Specialty Centers, Research & Academic Institutes)
- Kuwait Indication Outlook (Revenue, USD Million, 2018 - 2030)
- Middle East & Africa Indication Outlook (Revenue, USD Million, 2018 - 2030)
- North America
Report content
Qualitative Analysis
- Industry overview
- Industry trends
- Market drivers and restraints
- Market size
- Growth prospects
- Porter’s analysis
- PESTEL analysis
- Key market opportunities prioritized
- Competitive landscape
- Company overview
- Financial performance
- Product benchmarking
- Latest strategic developments
Quantitative Analysis
- Market size, estimates, and forecast from 2018 to 2030
- Market estimates and forecast for product segments up to 2030
- Regional market size and forecast for product segments up to 2030
- Market estimates and forecast for application segments up to 2030
- Regional market size and forecast for application segments up to 2030
- Company financial performance
GET A FREE SAMPLE
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.
Contact us now to get our best pricing.
ESOMAR certified & member
ISO Certified
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.
